Emergence of antimicrobial-resistant shigellosis in Oregon

Clinical Infectious Diseases

Volumn 30, Issue 3, 2000, Pages 515-519

  Replogle, Marilyn L ^a   Fleming, David W ^b   Cieslak, Paul R ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON PUBLIC HEALTH DIVISION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFIXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; HIGH RISK POPULATION; INCIDENCE; NONHUMAN; PRIORITY JOURNAL; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SHIGELLOSIS; UNITED STATES;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DYSENTERY, BACILLARY; FECES; FEMALE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; OREGON; SHIGELLA SONNEI;

EID: 0034116304     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313715     Document Type: Article

References (38)

1. 1. DuPont HL. Shigella species (bacillary dysentery). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 5th ed. Vol 2. New York: Churchill Livingstone, 2000:2363-9.
2. 2. Lolekha S, Vibulbandhitkit S, Poonyarit P. Response to antimicrobial therapy for shigellosis in Thailand. Rev Infect Dis 1991; 13(Suppl 4):S342-6.
3. 3. Bennish ML, Salam MA, Hossain MA, et al. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis 1992; 14:1055-60.
4. 4. Thisyakorn U, Rienprayoon S. Shigellosis in Thai children: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 1992; 11:213-5.
5. 5. Ashkenazi S, May-Zahav M, Sulkes J, Zilberberg R, Samra Z. Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992. Antimicrob Agents Chemother 1995; 39:819 23.
6. 6. Brito-Alayon NE, Blando AM, Monzon-Moreno C. Antibiotic resistance patterns and plasmid profiles for Shigella species isolated in Cordoba, Argentina. J Antimicrob Chemother 1994; 34:253-9.
7. 7. Ries AA, Wells JG, Olivola D, et al. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention. J Infect Dis 1994; 169:1035-41.
8. 8. Lima AAM, Lima NL, Pinho MCN, et al. High frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, streptomycin, chloramphenicol, and tetracycline isolated from patients with shigellosis in northeastern Brazil during the period 1988 to 1993. Antimicrob Agents Chemother 1995; 39:256-9.
9. 9. Mamun K, Hussain M, Shears P. Antimicrobial susceptibility of Shigella from a rural community in Bangladesh. Ann Trop Med Parasitol 1997; 91:643-7.
10. 10. Townes JM, Quick R, Gonzales OY, et al. Etiology of bloody diarrhea in Bolivian children: implications for empiric therapy. J Infect Dis 1997; 175: 1527-30.
11. 11. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998; 26:341-5.
12. 12. Tauxe RV, Puhr ND, Wells JG, Hargrett-Bean N, Blake PA. Antimicrobial resistance of Shigella isolates in the USA: the importance of international travelers. J Infect Dis 1990; 162:1107-11.
13. 13. Gilbert DN, Moellering RC Jr, Sande MA. The Sanford guide to antimicrobial therapy. 29th ed. Hyde Park, VT: Antimicrobial Therapy, Inc., 1999:50.
14. 14. Bartlett JG. Pocket book of infectious disease therapy. 9th ed. Baltimore: Williams & Wilkins, 1998:297.
15. 15. American Academy of Pediatrics. Shigella infections. In: Peter G, ed. 1997 red book: report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics, 1997:472-4.
16. 16. Shigellosis (bacillary dysentery). In: Chin, J, ed. Control of communicable diseases manual. 17th ed. Washington, DC: American Public Health Association, 2000:451-5.
17. 17. Woods GL, Washington JA. Antibacterial susceptibility tests: dilution and disk diffusion methods. In: Murray PR, Baron F.J, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. 6th ed. Washington, DC: ASM Press, 1995:1327-41.
18. 18. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial disk susceptibility tests: approved standard. 6th ed. NCCLS document M2-A6. Wayne, PA: NCCLS, 1997.
19. 19. U.S. Bureau of the Census. Estimates of the population of states by age, sex, race, and Hispanic origin, 1997. Washington, DC: US Bureau of the Census, 1998. Available at: http://www.census.gov/population/estimates/ county/crh. Accessed 3/1/2000.
20. 20. Cheasty T, Skinner JA, Rowe B, Threlfall EJ. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy. Microb Drug Resist 1998; 4:57-60.
21. 21. Harnett N. High level resistance to trimethoprim, co-trimoxazole and other antimicrobial agents among clinical isolates of Shigella species in Ontario, Canada - an update. Epidemiol Infect 1992; 109:463-72.
22. 22. Aleksic S, Katz A, Aleksic V, Bockemühl J. Antibiotic resistance of Shigella strains isolated in the Federal Republic of Germany 1989-1990. Int J Med Microbiol Virol Parasitol Infect Dis 1993; 279:484-93.
23. 23. Casalino M, Nicoletti M, Salvia A, et al. Characterization of endemic Shigella flexneri strains in Somalia: antimicrobial resistance, plasmid profiles, and serotype correlation. J Clin Microbiol 1994; 32:1179-83.
24. 24. Aseffa A, Gedlu E, Asmelash T. Antibiotic resistance of prevalent Salmonella and Shigella strains in northwest Ethiopia. East Afr Med J 1997; 74: 708-13.
25. 25. Threlfall EJ, Frost JA, Ward LR, Rowe B. Increasing spectrum of resistance in multiresistant Salmonella Typhimurium [letter]. Lancet 1996; 347: 1053-4.
26. 26. Glynn MK, Bopp C, Dewitt W, Dabney P, Mokhtar M, Angulo FJ. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium DT104 infections in the United States. N Engl J Med 1998; 338:1333-8.
27. 27. Munshi MH, Sack DA, Haider K, Ahmed ZU, Rahaman MM, Morshed MG. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet 1987; 2:419-21.
28. 28. Tuttle J, Ries AA, Chimba RM, Perera CU, Bean NH, Griffin PM. Antimicrobial-resistant epidemic Shigella dysenteriae type 1 in Zambia: modes of transmission. J Infect Dis 1995; 171:371-5.
29. 29. Threlfall EJ, Frost JA, Ward LR, Rowe B. Epidemic in cattle and humans of Salmonella Typhimurium DT 104 with chromosomally integrated multiple drug resistance. Vet Rec 1994; 134:577.
30. 30. Mirza SH, Hart CA. Plasmid encoded multi-drug resistance in Salmonella Typhi from Pakistan. Ann Trop Med Parasitol 1993; 87:373-7.
31. 31. Tauxe RV, Cavanagh TR, Cohen ML. Interspecies gene transfer in vivo producing an outbreak of multiply resistant shigellosis. J Infect Dis 1989; 160:1067-70.
32. 32. Lima AA, Sidrim JJ, Lima NL, Titlow W, Evans ME, Greenberg RN. Molecular epidemiology of multiply antibiotic-resistant Shigella flexneri in Fortaleza, Brazil. J Clin Microbiol 1997; 35:1061-5.
33. 33. Bennish ML, Salam MA, Khan WA, Khan AM. Treatment of shigellosis: III. Comparison of one-or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial. Ann Intern Med 1992; 117:727-34.
34. 34. Salam MA, Bennish ML. Antimicrobial therapy for shigellosis. Rev Infect Dis 1991; 13(Suppl4):S332-41.
35. 35. Burkhardt JE, Walterspiel JN, Schaad UB. Quinolone arthropathy in animals versus children. Clin Infect Dis 1997; 25:1196-204.
36. 36. Hampel B, Hullmann R, Schmidt H. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use - safety report. Pediatr Infect Dis J 1997; 16:127-9; discussion 160-2.
37. 37. Ashkenazi S, Amir J, Waisman Y, et al. A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis. J Pediatr 1993; 123:817-21.
38. 38. Salam MA, Seas C, Khan WA, Bennish ML. Treatment of shigellosis. IV. Cefixime is ineffective in shigellosis in adults. Ann Intern Med 1995; 123: 505-8.